UK Markets closed

Corcept Therapeutics Incorporated (0I3Q.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
20.76-0.23 (-1.07%)
At close: 01:30PM GMT
Full screen
Previous close20.99
Bid0.00 x 0
Ask0.00 x 0
Day's range20.76 - 20.76
52-week range20.76 - 20.76
Avg. volumeN/A
Market cap2.07B
Beta (5Y monthly)0.55
PE ratio (TTM)24.42
EPS (TTM)0.85
Earnings date03 May 2023 - 08 May 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A

    5 big stock buybacks: Verisk, Con Edison | Pro Recap

    Here are 5 biggest share buyback announcements from the past week you may have missed on InvestingPro. Verisk Analytics (NASDAQ:VRSK) announced that it has entered into accelerated share repurchase agreements with each of Citibank, and Goldman Sachs to repurchase an aggregate of $2.5B of the company's common stock. Morgan Stanley said on Thursday it's adding a position to the company, given (1) industry-standard network effects in an attractive industry, (2) attractive valuation after the company’s return to its traditional property and casualty-focused end markets after selling non-core business segments, and (3) from a portfolio perspective, reduces the Model’s volatility and exposure to consumer discretionary while adding exposure to high-quality industrials.

  • Simply Wall St.

    Corcept Therapeutics Full Year 2022 Earnings: EPS Misses Expectations

    Corcept Therapeutics ( NASDAQ:CORT ) Full Year 2022 Results Key Financial Results Revenue: US$401.9m (up 9.8% from FY...

  • Zacks

    Corcept's (CORT) Q4 Earnings and Revenues Miss Estimates

    Corcept Therapeutics' (CORT) fourth-quarter earnings and revenues lag estimates.